Feb 26 (Reuters) - Nanosonics Ltd (NAN) :
- HALF YEAR REVENUE OF A$79.6 MILLION, DOWN 2%
- CONTINUES TO TARGET SUBMISSION OF FDA DE NOVO APPLICATION FOR CORIS BY END OF Q3 FY24
- TOTAL REVENUE IN H2 IS EXPECTED TO GROW BETWEEN 6-15% OVER H1
- HY GROSS PROFIT MARGIN OF 79.7%, UP FROM 78.9% IN PCP
- EXPECT BOTH UNIT AND REVENUE GROWTH IN H2 OVER H1
- FULL YEAR REVENUE IS EXPECTED TO BE BETWEEN A$164 MILLION AND A$171 MILLION
- HY OPERATING PROFIT BEFORE TAX OF A$4.9 MILLION VERSUS A$11.4 MILLION
Feb 26 (Reuters) - Nanosonics Ltd (NAN) : HALF YEAR REVENUE OF...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.02 |
Change
-0.050(1.23%) |
Mkt cap ! $1.220B | |||
| Open | High | Low | Value | Volume |
| $4.07 | $4.09 | $3.89 | $5.292M | 1.318M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 94 | $3.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.05 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| NAN (ASX) Chart |